Literature DB >> 3602925

Screening for colorectal carcinoma in cancer family syndrome kindreds.

J P Mecklin, H J Järvinen, S Aukee, I Elomaa, K Karjalainen.   

Abstract

Screening for colorectal carcinoma (CRC) was organized for 236 asymptomatic family members in 22 Finnish cancer family syndrome (CFS) kindreds, and 58% (137) of the subjects accepted the invitation. Double-contrast colonography and sigmoidoscopy or colonoscopy were used. In 137 subjects aged 20-65 years, with 3 or more first-degree relatives with CRC, one screening visit showed a colonic neoplasm in 12 (9%) subjects. Two had carcinoma (Dukes A and B), and 10 subjects one or more adenomas. Two of the subjects not attending screening (2%) developed Dukes C colon carcinoma during the study period, and one of them died of cancer. Continued screening of 34 patients with a previously identified CFS showed metachronous colorectal tumours in 12 (35%) cases: 9 operable carcinomas and 9 adenomas within 3 years. The preliminary result of screening on the basis of CFS was encouraging. Effective and continuous screening, however, requires centralized organization. The continued follow-up of identified CFS cases effectively revealed metachronous colorectal tumours at a curable stage, but its benefit was burdened by a high rate of advanced malignancies other than CRC.

Entities:  

Mesh:

Year:  1987        PMID: 3602925     DOI: 10.3109/00365528708991489

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  12 in total

1.  Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.

Authors:  P J Westlake; H E Bryant; S A Huchcroft; L R Sutherland
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

2.  Quantitative MRI using STrategically Acquired Gradient Echo (STAGE): optimization for 1.5 T scanners and T1 relaxation map validation.

Authors:  Alice Pirastru; Yongsheng Chen; Laura Pelizzari; Francesca Baglio; Mario Clerici; E Mark Haacke; Maria Marcella Laganà
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

3.  Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families.

Authors:  Kirsi Pylvänäinen; Matti Kairaluoma; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 4.  Colorectal surveillance in Lynch syndrome families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Heikki J Järvinen; Patrick M Lynch; Christoph Engel; Jukka-Pekka Mecklin; Hans F A Vasen
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  How prevalent is cancer family syndrome?

Authors:  F Kee; B J Collins
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Evolution of hereditary non-polyposis colorectal cancer.

Authors:  J R Jass; S M Stewart
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

7.  Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.

Authors:  Annelie Liljegren; Gail Barker; Faye Elliott; Lucio Bertario; Marie Luise Bisgaard; Diana Eccles; Gareth Evans; Finlay Macrae; Eamonn Maher; Annika Lindblom; Samuel Rotstein; Bo Nilsson; Jukka-Pekka Mecklin; Gabriela Möslein; Jeremy Jass; Riccardo Fodde; John Mathers; John Burn; D Timothy Bishop
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

8.  Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.

Authors:  H F Vasen; B G Taal; G Griffioen; F M Nagengast; A Cats; F H Menko; W Oskam; J H Kleibeuker; G J Offerhaus; P M Khan
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 9.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

Authors:  H F A Vasen; G Möslein; A Alonso; I Bernstein; L Bertario; I Blanco; J Burn; G Capella; C Engel; I Frayling; W Friedl; F J Hes; S Hodgson; J-P Mecklin; P Møller; F Nagengast; Y Parc; L Renkonen-Sinisalo; J R Sampson; A Stormorken; J Wijnen
Journal:  J Med Genet       Date:  2007-02-27       Impact factor: 6.318

Review 10.  Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.

Authors:  Hans F A Vasen
Journal:  Fam Cancer       Date:  2021-01-19       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.